/Companies

Healthtech Startups

18,755 companies tagged Healthtech, with their investors and founders.

HALSAmd

0 investors

HALT Medical

0 investors

Hamilton Surgery Center Group

0 investors

Han Benefit Advantage

0 investors

Hancock Jaffe Laboratories Aesthetics

0 investors

Hancock Medical

0 investors

Hancock Regional Surgery Center

0 investors

Hand In Hand Health

0 investors

Hannah's

Hannah Pet Hospital provides veterinary care through a subscription model with a predictable monthly fee covering medical, dental, emergency, diagnostics, medications, and behavior support. It serves pet owners seeking to avoid cost-based medical decisions, delivering care at its own locations with a focus on prevention.

0 investors

Hapten Sciences

Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants. The company targets healthcare providers and individuals affected by urushiol-related skin conditions.

0 investors

Harborview Healthcare

0 investors

Harmonia Healthcare

0 investors

Harmonus

0 investors

Harren HCA

0 investors

Hart

0 investors

Harvard Apparatus Regenerative Technology

HRGN (Harvard Apparatus Regenerative Technology, operating Biostage) is a clinical-stage regenerative medicine company developing treatments for esophageal conditions, including a therapy for esophageal atresia, a congenital defect affecting newborns. Its lead candidate entered a Phase 1 clinical trial in 10 patients at sites including Mayo Clinic and the University of Michigan.

0 investors

Hastings Medical Imaging

Hastings Radiology Associates provides diagnostic imaging services including CT, MRI, ultrasound, mammography, and interventional procedures to patients in central Nebraska and north central Kansas.

0 investors

Hat Trick Medical

0 investors

Hatchcares

0 investors

Hatcher Pass Surgery Center

0 investors

Hauppauge SC

0 investors

Hauppauge SC Holdings

0 investors

Havah Therapeutics

HavaH Therapeutics develops T+Ai, a subcutaneous extended-release pellet combining testosterone and anastrozole, aimed at preventing and treating hormone receptor positive breast cancer, including ductal carcinoma in situ (DCIS) and ER+ disease. The clinical-stage company targets the intra-mammary hormonal balance to slow tumor growth and reduce the need for surgery.

0 investors

Hawaiian Ethos

0 investors

Other sectors & tags